215 related articles for article (PubMed ID: 11279206)
21. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
[TBL] [Abstract][Full Text] [Related]
22. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
23. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
24. VHY, a novel myristoylated testis-restricted dual specificity protein phosphatase related to VHX.
Alonso A; Narisawa S; Bogetz J; Tautz L; Hadzic R; Huynh H; Williams S; Gjörloff-Wingren A; Bremer MC; Holsinger LJ; Millan JL; Mustelin T
J Biol Chem; 2004 Jul; 279(31):32586-91. PubMed ID: 15138252
[TBL] [Abstract][Full Text] [Related]
25. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
26. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
27. The TPTE gene family: cellular expression, subcellular localization and alternative splicing.
Tapparel C; Reymond A; Girardet C; Guillou L; Lyle R; Lamon C; Hutter P; Antonarakis SE
Gene; 2003 Dec; 323():189-99. PubMed ID: 14659893
[TBL] [Abstract][Full Text] [Related]
28. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.
Torres J; Pulido R
J Biol Chem; 2001 Jan; 276(2):993-8. PubMed ID: 11035045
[TBL] [Abstract][Full Text] [Related]
29. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
30. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
31. Interactions of phosphatase and tensin homologue (PTEN) proteins with phosphatidylinositol phosphates: insights from molecular dynamics simulations of PTEN and voltage sensitive phosphatase.
Kalli AC; Devaney I; Sansom MS
Biochemistry; 2014 Mar; 53(11):1724-32. PubMed ID: 24588644
[TBL] [Abstract][Full Text] [Related]
32. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
[TBL] [Abstract][Full Text] [Related]
33. Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity.
Caffrey JJ; Darden T; Wenk MR; Shears SB
FEBS Lett; 2001 Jun; 499(1-2):6-10. PubMed ID: 11418101
[TBL] [Abstract][Full Text] [Related]
34. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
35. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
[TBL] [Abstract][Full Text] [Related]
36. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
Mahimainathan L; Choudhury GG
J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the PTEN tail regulates protein stability and function.
Vazquez F; Ramaswamy S; Nakamura N; Sellers WR
Mol Cell Biol; 2000 Jul; 20(14):5010-8. PubMed ID: 10866658
[TBL] [Abstract][Full Text] [Related]
39. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
[TBL] [Abstract][Full Text] [Related]
40. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
